Literature DB >> 2989522

Synthesis and biological activities of 2-pyrimidinone nucleosides. 2. 5-Halo-2-pyrimidinone 2'-deoxyribonucleosides.

S M Efange, E M Alessi, H C Shih, Y C Cheng, T J Bardos.   

Abstract

1-(2-Deoxy-beta-D-ribofuranosyl)-5-bromo-2-pyrimidinone (BrPdR) and 1-(2-deoxy-beta-D-ribofuranosyl)-5-iodo-2-pyrimidinone (IPdR) have been synthesized by condensation of the appropriate silylated bases 2a and 2b, respectively, with 3,5-bis-O-(p-chlorobenzoyl)-2-deoxy-alpha-D-ribofuranosyl chloride (8) in 1,2-dichloroethane, in the presence of SnCl4, followed by separation of the anomeric blocked nucleosides via column chromatography and subsequent deprotection with methanolic ammonia. Both BrPdR and IPdR exhibited significant antiherpes activities against various strains of HSV-1 and HSV-2, the latter compound (IPdR) showing the higher activity as well as the stronger binding to the virus-specific thymidine kinase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2989522     DOI: 10.1021/jm00145a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  5-iodo-2-pyrimidinone-2'-deoxyribose-mediated cytotoxicity and radiosensitization in U87 human glioblastoma xenografts.

Authors:  Timothy J Kinsella; Michael T Kinsella; Yuji Seo; Gregory Berk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-15       Impact factor: 7.038

2.  Anti-herpes simplex virus activity of 5-substituted 2-pyrimidinone nucleosides.

Authors:  G A Lewandowski; S P Grill; M H Fisher; G E Dutschman; S M Efange; T J Bardos; Y C Cheng
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

3.  Differential Inhibition of APOBEC3 DNA-Mutator Isozymes by Fluoro- and Non-Fluoro-Substituted 2'-Deoxyzebularine Embedded in Single-Stranded DNA.

Authors:  Maksim V Kvach; Fareeda M Barzak; Stefan Harjes; Henry A M Schares; Harikrishnan M Kurup; Katherine F Jones; Lorraine Sutton; John Donahue; Richard T D'Aquila; Geoffrey B Jameson; Daniel A Harki; Kurt L Krause; Elena Harjes; Vyacheslav V Filichev
Journal:  Chembiochem       Date:  2019-12-19       Impact factor: 3.164

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.